Further studies suggest that cyclin E activation is dependent upon the activation of the MAPK pathway following mitogenic stimulation [10,11], and lots of researchers have found that, compared with normal tissue, cyclin E is highly expressed in most liver cancers [12]. The gene discussed is CCNE1; the disease is liver cancer.